Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Vaccination mot typ 1-diabetes framme vid kliniska försöksstadiet

Vaccination against type I diabetes at the clinical trial stage

Author

  • Åke Lernmark

Summary, in English

The occurrence of type I diabetes is associated with autoimmunity against insulin, glutamate decarboxylase (GAD65) and the transmembrane protein IA-2. Experiments in the spontaneously diabetic NOD mouse and the BB rat have shown early autoantigen treatment to confer protection from diabetes. The question remains of whether human type I diabetes can be prevented by autoantigen 'vaccination'.

Publishing year

1999-12-01

Language

Swedish

Pages

1300-1302

Publication/Series

Läkartidningen

Volume

96

Issue

11

Document type

Journal article

Publisher

Swedish Medical Association

Status

Published

ISBN/ISSN/Other

  • ISSN: 0023-7205